Navigation Links
Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
Date:8/19/2007

Oncomine and Oncomine Concepts Map Integral in Expression and Association

Analyses

ANN ARBOR, Mich., Aug. 2 /PRNewswire/ -- Building on an earlier study that used Oncomine(TM) to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. today report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070213/NYTU093LOGO )

Tomlins et al. queried the Oncomine database to determine the tissue specificity of three of the new fusion gene partners, demonstrating that two new partners are prostate cancer specific while the third partner is a generally over-expressed 'house-keeping' gene. In addition, Oncomine Concepts Map was applied to test for similarities between the set of genes regulated by ETV1 with sets of genes related to other biological concepts. This analysis revealed a clear association between ETV1 activation and cellular invasion, a hallmark of cancer.

Oncomine, a dynamic repository that combines rich data, sophisticated analysis, and responsive user interface, empowers oncology research by bringing data analysis tools to a large cancer gene expression database, which includes data from 20,000+ microarray experiments curated from 300+ independent studies. Oncomine Concepts Map, an extension of Oncomine, is a compilation of nearly 8,000 Oncomine cancer gene signatures together with 11,500 gene, protein, drug, and pathway signatures collected from the literature and other public sources.

"This study marks an important advance in our understanding of the molecular basis of prostate cancer. Oncomine again proved invaluable in examining the expression of genes in cancer, and in this case aided in the characterization of n
'/>"/>

SOURCE Compendia Bioscience, Inc.

Copyright©2007 PR Newswire.

Page: 1 2

Related medicine technology :

1. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
2. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
3. Protox Announces Positive Clinical Data from Prostate Cancer Study
4. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
5. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
6. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
7. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
8. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
9. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
10. Quest PharmaTechs Prostate Cancer Program Update
11. Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009).... 9 AMD LASERS just announced that...esse, has accepted the position of Medical Directo... for overseeing research and development of new so...mpliance for continuing education credits, authori...lications, and lecturing and seminar engagements. ...
(Date:11/9/2009)...Nov. 9 Access MediQuip, LLC, the n...mplantable medical device management solutions to ...s relocating its corporate headquarters to Lake Ma...tinued rapid growth, includes a major expansion of...l open in January 2010 and relocation and expansio...
(Date:11/9/2009)... Nov. 9 Thomson Reuters today an...areFocus, a leading clinical surveillance solution...ts in real-time and respond immediately to improve...nt. ,, This upgrade is available to current Car...reFocus 2.0 contains several powerful enhancements...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Bioethanols impact on water supply 3 times higher than once thought 9482 1The Reduction of Eye Fatigue Improves Vision in Older Subjects 53740 1The Reduction of Eye Fatigue Improves Vision in Older Subjects 53740 2Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma 53737 1Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma 53737 2
... -- 100 percent response rate achieved with VELCAD...June 28 /PRNewswire-FirstCall/ -- Millennium,Pharm...the,presentation of results from four clinical tri...ently high survival and complete,remission / compl...iple myeloma (MM) patients. These data were presen...
... - Data Presented at the 11th International Myelom...eece, June 29, 2007,/PRNewswire/ -- The Internatio...h and providing education, advocacy and support,fo...icians -- today,said that updated statistics repor...Greece demonstrate improved survival for a wide,ra...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 2Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 3Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 5Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 6Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 7Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 8The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 2The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 3The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 4
(Date:11/9/2009)...ed with new cells regained sexual function, study ...ews) -- Researchers were able to restore sexual fu...new penile tissue in the lab and implanting it, a ... is a ways off, researchers say the technique coul...tion in men. , "We were able to show the tissue...
(Date:11/9/2009)... Tomorrow may be too late when it comes ...ccording to TOPS Club, Inc. (Take Off Pounds Sensi...on. , (Vocus) November 9,... preventing or improving a diabetes condition, acc...y), the nonprofit weight-loss support organization...
(Date:11/9/2009)...ICA, Calif., Nov. 9 Actress Marisk...ned philosophy on Saturday to raise awareness ...ces throughout California by building healing and ...h kits were created to give one to each of the est...Los Angeles County,s domestic violence shelters. ,...
(Date:11/9/2009)...Nov. 9 For the third co...nter has been selected the most preferred hospital...to a survey by the National Research Corporation. ...h/20071106/KARMANOSLOGO ) ,, The annual survey...een September 2008 and August 2009. Survey respond...
(Date:11/9/2009)... Nov. 9 /PRNewswire/ -- Phoenix House , the n...treatment and prevention program, announced today ...y and internationally recognized leader in substan... Officer, effective January 1, 2010. ,, "Dr. ...abuse treatment research and her work has resulted...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3
..., Ind., Sept. 27 Conseco, Inc. (NYSE:,CNO) will h... care business,at 3:00 p.m. Eastern Daylight Time ...nce call earlier today, a technical problem at a s...70 and use the,Conference ID 18906493. The presen...
...IA, Md., Sept. 27 Martek Biosciences, a,DHA omega...has introduced,under the Bellybar(TM) brand, new a...M), Martek,s patented, vegetarian form of DHA omeg...50 mg per bar of life,sDHA(TM), a fatty acid impor...
...T NEWS, Va., Sept. 27 The Patient,Advocate Founda...hat,provides patient services to tens of thousands...ccess to care because of financial or insurance,de...amthun; Pearl Moore, RN; Alan Balch, PhD; and Venu...
...ng members to search areas of expertise and other ...herapist, EDEN PRAIRIE, Minn., Sept. 27 CIGNA Be... online provider profiles that offer a,photograph ... experience. Available at http://www.cignabehavio...
...a is leading cause of parasitic infections in U.S...sts have sequenced the genome of the intestinal pa...n 20,000 reported infections a year in the United ...act Giardia through contact with infected stool or...
... ARBOR, Mich. People who have the common chronic ... dont respond to the types of medication that reli...ersity of Michigan Health System helps to explain ...id painkiller drugs such as morphine. , The study...
Other Medicine News:Health News:Martek Announces Addition of life'sDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars 2Health News:Martek Announces Addition of life'sDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars 3Health News:Patient Advocate Foundation Welcomes Leading Health Care Experts to Executive Board of Directors 2Health News:Patient Advocate Foundation Welcomes Leading Health Care Experts to Executive Board of Directors 3Health News:CIGNA Behavioral Health Offers Members Online Provider Profiles 2Health News:Scientists Map Intestinal Bug's Genome 2Health News:Why don't painkillers work for people with fibromyalgia? 2
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: